2014 Pharmacy LW 30 JUL Recording |
Course Description
Target-Specific Oral Anticoagulants
in Non-Valvular Atrial Fibrillation
Presented July 30, 2014 via Adobe Connect
Course Faculty
CDR Ryan Schupbach, PharmD, BCPS (Claremore, OK)
Release Date: July 30, 2014
Estimated Time to Complete Course: 1.0 hour
Target Audience: Pharmacists working in I/T/U settings
Course Overview:
The IHS Pharmacy Last Wednesdays Webinar Series has been initiated to address the needs of pharmacists and pharmacy technicians in I/T/U settings. Specifically, the series address five (5) areas: 1. Recent Evidence-Based Therapeutic Guidelines; 2. New Practices/Clinical Collaboration Models within IHS; 3. The Scope of Practice and Standards of Practice of IHS Pharmacy; 4. Ongoing Professional/Legal Changes in the Pharmacy Profession; and 5. Issues Confronting Institutional or Ambulatory Care Practice.
Learning Objectives:
As a result of completing this training, participants will be able to:
1. Review landmark studies comparing TSOAs to warfarin
2. Contrast advantages and disadvantages of the TSOAs compared to warfarin
3. Identify patient characteristics that improve TSOA candidacy
This recorded webinar is not eligible for continuing education credits but is availble as an additional educational resource.
in Non-Valvular Atrial Fibrillation
Presented July 30, 2014 via Adobe Connect
Course Faculty
CDR Ryan Schupbach, PharmD, BCPS (Claremore, OK)
Release Date: July 30, 2014
Estimated Time to Complete Course: 1.0 hour
Target Audience: Pharmacists working in I/T/U settings
Course Overview:
The IHS Pharmacy Last Wednesdays Webinar Series has been initiated to address the needs of pharmacists and pharmacy technicians in I/T/U settings. Specifically, the series address five (5) areas: 1. Recent Evidence-Based Therapeutic Guidelines; 2. New Practices/Clinical Collaboration Models within IHS; 3. The Scope of Practice and Standards of Practice of IHS Pharmacy; 4. Ongoing Professional/Legal Changes in the Pharmacy Profession; and 5. Issues Confronting Institutional or Ambulatory Care Practice.
Learning Objectives:
As a result of completing this training, participants will be able to:
1. Review landmark studies comparing TSOAs to warfarin
2. Contrast advantages and disadvantages of the TSOAs compared to warfarin
3. Identify patient characteristics that improve TSOA candidacy
This recorded webinar is not eligible for continuing education credits but is availble as an additional educational resource.